Christiana Bardon

Christiana Bardon discloses dealings in F-star Therapeutics, Inc. to SEC (Form 4). Between 2 April 2018 and 1 October 2018, the trades on record add up to 3 filings.

Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The latest filing, published on 3 October 2018, reports a share grant in F-star Therapeutics, Inc. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.